Skip to content

Clinical registry study of therapeutic embolization in the treatment of high grade cerebral arteriovenous malformations

Clinical registry study of therapeutic embolization in the treatment of high grade cerebral arteriovenous malformations

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037657
Enrollment
Unknown
Registered
2020-08-29
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral arteriovenous malformation

Interventions

A:Fractional partial embolization according to the circumstances
Onyx was injected into two microcatheters of large blood supply arteries according to double-catheter technique, and blood pressure was strictly controlled after operation.
Intraoperative control hypotension was adopted.Blood pressure was strictly controlled after operation.

Sponsors

The First Affiliated Hospital of PLA Navy Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. BAVM patients; 2. Aged >= 13 and <= 60 years; 3. The informed consent is signed by the patient himself or his legal guardian or representative.

Exclusion criteria

Exclusion criteria: 1. AVM has a history of embolization, radiation therapy or partial resection. 2. MRS >= 3 points due to intracranial hemorrhage or neurological dysfunction before treatment; 3. Radiologically confirmed complicated with ruptured aneurysm; 4. AVM is too diffuse;Platelet count 1.4, or TP or ATPP increased; 5. Any irreversible clotting disorder or known clotting disorder; 6. Patients requiring long-term anticoagulation; 7. Premenopausal women with positive urine or plasma pregnancy tests (no recorded history of surgical sterilization); 8. Major concomitant diseases such as liver, kidney, gastrointestinal, respiratory, cardiovascular, endocrine, immune and hematological diseases that are subject to imaging safety assessment.

Design outcomes

Primary

MeasureTime frame
Immediate embolization rate after the last endovascular treatment;The vascular malformation occlusion rate was followed up 2 years after operation.;

Secondary

MeasureTime frame
Cerebral hemorrhage and ischemic events within one week after the end of the last embolization were included;Intracerebral hemorrhage during clinical follow-up from 1 week after the last embolization to 2 years;MRS scores were obtained during the last clinical follow-up 2 years after surgery;

Countries

China

Contacts

Public ContactQiang Li

The PLA Naval Medical University

lqeimm@126.com+86 13818803656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026